Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

ER+HER2- Breast Cancer 1

Interventions

Carboplatin 79 Cisplatin 74 Bevacizumab 62 Radiotherapy 59 Drug Therapy 57 Capecitabine 57 Oxaliplatin 56 tislelizumab 54 toripalimab 45 Paclitaxel 44 Gemcitabine 43 Specimen Handling 41 pembrolizumab 40 anlotinib 40 sintilimab 37 Cyclophosphamide 34 130-nm albumin-bound paclitaxel 34 Injections 29 Pemetrexed 28 camrelizumab 26 Surgical Procedures, Operative 26 Magnetic Resonance Spectroscopy 26 lenvatinib 24 apatinib 23 Docetaxel 23 Etoposide 22 Biopsy 22 S 1 (combination) 21 Fluorouracil 21 Immune Checkpoint Inhibitors 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Not yet recruiting × 18-O-demethylcervinomycin A2 × Clear all

NCT07109284 2025-08-07

NeoSaciA

West China Hospital

Phase 2 Not yet recruiting

ER+HER2- Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡